AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From AFX Europe (Focus))
ZURICH (AFX) - Roche Holding AG announced it has acquired Therapeutic Human Polyclonals Inc (THP), a privately-owned biotechnology company based in California and Germany, for 56.5 mln usd in cash.
The company, which is focusing on antibody research, will be integrated into Roche's pharma centre of excellence for protein research in Penzberg, Germany, the Basel-based drugs maker said.
"We are delighted about this acquisition as it builds on our strength in therapeutic ...